Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex
- 10 November 2022
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 42 (1) , 11-25
Abstract
EWS/ETS fusion transcription factors, most commonly EWSR1::FLI1, drives initiation and progression of Ewing sarcoma (EwS). Even though direct targeting EWSR1::FLI1 is a formidable challenge, epigenetic/transcriptional modulators have been proved to be promising therapeutic targets for indirectly disrupting its expression and/or function. Here, we identified structure-specific recognition protein 1 (SSRP1), a subunit of the Facilitates Chromatin Transcription (FACT) complex, to be an essential tumor-dependent gene directly induced by EWSR1::FLI1 in EwS. The FACT-targeted drug CBL0137 exhibits potent therapeutic efficacy against multiple EwS preclinical models both in vitro and in vivo. Mechanistically, SSRP1 and EWSR1::FLI1 form oncogenic positive feedback loop via mutual transcriptional regulation and activation, and cooperatively promote cell cycle/DNA replication process and IGF1R-PI3K-AKT-mTOR pathway to drive EwS oncogenesis. The FACT inhibitor drug CBL0137 effectively targets the EWSR1::FLI1-FACT circuit, resulting in transcriptional disruption of EWSR1::FLI1, SSRP1 and their downstream effector oncogenic signatures. Our study illustrates a crucial role of the FACT complex in facilitating the expression and function of EWSR1::FLI1 and demonstrates FACT inhibition as a novel and effective epigenetic/transcriptional-targeted therapeutic strategy against EwS, providing preclinical support for adding EwS to CBL0137’s future clinical trials.Keywords
Funding Information
- National Natural Science Foundation of China (81572761, 81772655 and 81972646, 82002978, 81572692, 82171696)
- China Postdoctoral Science Foundation (2019M651527)
This publication has 62 references indexed in Scilit:
- Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancerGenome Research, 2013
- GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq dataBioinformatics, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaNature Genetics, 2012
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationProceedings of the National Academy of Sciences, 2009
- EWS-Fli1 Up-Regulates Expression of the Aurora A and Aurora B KinasesMolecular Cancer Research, 2008
- Model-based Analysis of ChIP-Seq (MACS)Genome Biology, 2008
- Microsatellites as EWS/FLI response elements in Ewing's sarcomaProceedings of the National Academy of Sciences, 2008
- Gene expression analyses reveal molecular relationships among 20 regions of the human CNSneurogenetics, 2006